Trial intelligence / Profile preview

Amoxicillin-clavulanate versus placebo for tic disorder with GAS colonization

2012-002430-36Phase 4Active

Sponsor
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in tic disorder, Tourette syndrome (TS) and chronic tic disorder comparing Amoxicillin-clavulanate with Placebo (2 arms). Primary endpoint: Yale Global Tic Severity Scale. Started Jul 2012; status: active.

02

Drugs

amoxicillin + clavulanate
03

Conditions

tic disorderTourette syndrome (TS)chronic tic disorder

Beyond the preview

Go deeper on 2012-002430-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002430-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call